Back

Transcriptional readthrough precedes alternative splicing programs triggered in CML cells by imatinib

Podszywalow-Bartnicka, P.; Shine, M.; Lin, J.; Neugebauer, K. M.

2025-11-05 molecular biology
10.1101/2025.11.04.686193 bioRxiv
Show abstract

Cellular stresses induce transcription readthrough, whereby RNA polymerase II elongates past a genes polyadenylation cleavage site without RNA cleavage. Readthrough has been reported in several cancer types. Here, we use long-read sequencing of nascent RNA to quantify transcriptional readthrough in chronic myelogenous leukemia (CML) cells and characterize early responses to the targeted therapeutic, imatinib. We show that the amount, length, and gene-specificity of readthrough increase within 1 hour, while gene expression and alternative splicing alterations emerge later. Strikingly, imatinib-dependent mRNA isoform changes involved "readthrough chimeras", in which exons from an upstream gene are alternatively spliced to exons in a downstream gene. Modifications in mRNA isoforms and chimera levels detected at 18 hours were also found in imatinib-resistant K562 as well as CML patient cells, suggesting a cascade of early changes in the fidelity of transcription and splicing, leading to long-term adjustment in gene expression and the development of therapy resistance. TeaserPrecision RNA sequencing was used to discover the earliest response of leukemia cells treated with targeted therapy: transcriptional readthrough.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.